2009
DOI: 10.1128/mmbr.00009-09
|View full text |Cite
|
Sign up to set email alerts
|

Lessons in Signaling and Tumorigenesis from Polyomavirus Middle T Antigen

Abstract: SUMMARY The small DNA tumor viruses have provided a very long-lived source of insights into many aspects of the life cycle of eukaryotic cells. In recent years, the emphasis has been on cancer-related signaling. Here we review murine polyomavirus middle T antigen, its mechanisms, and its downstream pathways of transformation. We concentrate on the MMTV-PyMT transgenic mouse, one of the most studied models of breast cancer, which permits the examination of in situ tumor progression from hyperp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
156
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 142 publications
(164 citation statements)
references
References 349 publications
3
156
0
Order By: Relevance
“…Probably as a consequence of the PyMT-mediated activation of PI3Ka 29 , we observed that orthotopically transplanted PyMT þ ;Rras2 À / À MECs could form tumours more efficiently than the immortalized breast cancer cells used in prior assays (Fig. 7d,e).…”
Section: R-ras2 Uses Different Downstream Effectors During Metastasismentioning
confidence: 59%
“…Probably as a consequence of the PyMT-mediated activation of PI3Ka 29 , we observed that orthotopically transplanted PyMT þ ;Rras2 À / À MECs could form tumours more efficiently than the immortalized breast cancer cells used in prior assays (Fig. 7d,e).…”
Section: R-ras2 Uses Different Downstream Effectors During Metastasismentioning
confidence: 59%
“…However, we hypothesize that ALTO/MT proteins likely perform related functions despite this low sequence and structural conservation, similar to many examples of disordered proteins that can accomplish very similar biological tasks (34). Consistent with this possibility of similar function, the second exons of MT proteins from MPyV and HamsterPyV are less than 20% identical, yet both MTs use short linear sequences, such as phosphatidylinositol-3 kinase motifs, whose location is not conserved between the two proteins but retention of these motifs has been shown to be important for the functions of both proteins (22). We have also identified putative short linear motifs among closely related ALTO proteins of MCPyV-related viruses (SI Appendix, Alignment S2).…”
Section: Subfunctionalizationmentioning
confidence: 78%
“…The main transforming activity of MPyV is encoded by the middle T antigen (MT), which splices the first exon corresponding to ST to the overprinting frame in exon 2. Studies of MT in MPyV have led to discoveries of phosphotyrosine kinases (PTK) and phosphoinositide 3-kinase (PI3K) signaling (9,22). Although ALTO does not appear to be essential for viral genome replication, we find that it is mutated in many cancer tissues and that elucidation of its function may uncover new roles for ALTO in MCPyV manipulation of human cell signaling and perhaps in cancer development.…”
Section: Discussionmentioning
confidence: 91%
See 1 more Smart Citation
“…The effects of dietary energy balance alterations, such as CR and diet-induced obesity (DIO), on ERa low luminal breast cancer are poorly characterized, at least in part due to a paucity of relevant animal models of this intrinsic subtype of breast cancer. Comparative oncogenomic studies on human and mouse mammary tumors show that tumors from the polyoma middle-T antigen transgenic mice cluster closely with human luminal B breast tumors and share many of the pathological and molecular hallmarks of human luminal B tumors (Herschkowitz et al 2007, Fluck & Schaffhausen 2009, Zhu et al 2011. Furthermore, the Met1 cell line, derived from a spontaneous tumor from a polyoma middle-T antigen transgenic mouse, progressively loses ER and progesterone receptor positivity with tumor progression, therefore providing a rapid and relevant model for studying ERa low luminal mammary tumor progression when orthotopically transplanted into syngeneic mice (Lin et al 2003, Borowsky et al 2005, Namba et al 2006, Bonuccelli et al 2009.…”
Section: Introductionmentioning
confidence: 99%